AI for improving clinical trials & drug development, entrepreneurship & AI safety | Charles Fisher

Dr. Charles Fisher is the CEO and Founder of Unlearn(dot)AI which helps in faster drug development and efficient clinical trials. This year they also raised a series B funding of 50 million dollars. Charles holds a Ph.D. in biophysics from Harvard University and prior to founding Unlearn, he did his Postdoctorate at Boston University, followed by being a principal scientist at Pfizer and a machine learning engineer at a virtual reality company in silicon valley.
Time stamps of the conversation
00:00:30 Introduction
00:01:16 What got you into Machine Learning?
00:04:10 Learning the basics and implementation
00:07:55 Digital twins for clinical trials and drug development
00:13:06 Patient heterogeneity in medical research
00:16:05 Error quantification of models
00:17:17 ML models for drug development
00:22:45 Adoption of AI in medical applications
00:25:35 Building trust in AI systems
00:35:10 How to show AI models are safe in real world?
00:38:38 Moving from academia to industry to entrepreneurship
00:45:08 Research projects in startups vs academia vs big companies
00:53:12 Routine as a CEO
00:57:50 Is PhD necessary for a research career in industry?
01:01:20 Taking inspiration from biology to improve machine learning
01:05:25 Advice to young people
About Charles:
LinkedIn: / drckf
More about Unlearn: www.unlearn.ai/
Also check-out these talks on all available podcast platforms: jayshah.buzzsprout.com
About the Host:
Jay is a PhD student at Arizona State University.
Linkedin: / shahjay22
Twitter: / jaygshah22
Homepage: www.public.asu.edu/~jgshah1/ for any queries.
Stay tuned for upcoming webinars!
**Disclaimer: The information contained in this video represents the views and opinions of the speaker and does not necessarily represent the views or opinions of any institution. It does not constitute an endorsement by any Institution or its affiliates of such video content.**